Arthur P. Bollon
Vorstandsvorsitzender bei Vitruvian BioMedical, Inc.
Aktive Positionen von Arthur P. Bollon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SignPath Pharma, Inc.
 SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Direktor/Vorstandsmitglied | 28.05.2008 | - |
| Independent Dir/Board Member | 28.05.2008 | - | |
Vitruvian BioMedical, Inc.
 Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX. | Vorstandsvorsitzender | 01.01.2011 | - |
| Vorsitzender | 01.01.2011 | - | |
| Gründer | 01.01.2011 | - |
Karriereverlauf von Arthur P. Bollon
Ehemalige bekannte Positionen von Arthur P. Bollon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Hemobiotech, Inc.
 Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Vorstandsvorsitzender | 01.10.2003 | 01.08.2010 |
| Vorsitzender | 01.10.2003 | 29.10.2009 | |
| Präsident | 01.10.2003 | 01.08.2010 | |
| Cytoclonal Pharmaceutics, Inc. | Vorstandsvorsitzender | 01.01.1992 | 01.01.2000 |
| Vorsitzender | 01.01.2000 | 01.01.2000 | |
| Gründer | 01.01.1992 | 01.01.2000 | |
| Präsident | - | 01.01.2000 | |
| Wadley Biosciences, Inc. | Vorstandsvorsitzender | 01.01.1987 | 01.01.1991 |
| Vorsitzender | 01.01.1991 | 01.01.1991 | |
| Gründer | 01.01.1991 | 01.01.1991 | |
| Präsident | - | 01.01.1991 | |
| IMMUNOTECH LABORATORIES, INC. | Direktor/Vorstandsmitglied | 18.12.2009 | - |
| Biogress LLC | Gründer | 21.12.2009 | - |
| Corporate Officer/Principal | 01.01.2003 | 21.12.2009 |
Ausbildung von Arthur P. Bollon
| The Waksman Institute of Microbiology | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Chief Executive Officer | 4 |
| Chairman | 4 |
| Founder | 4 |
Sektoral
| Health Technology | 4 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMMUNOTECH LABORATORIES, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |
| Biogress LLC | |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Commercial Services |
| Cytoclonal Pharmaceutics, Inc. | Health Technology |
| Wadley Biosciences, Inc. | |
Vitruvian BioMedical, Inc.
Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX. | Commercial Services |
- Börse
- Insiders
- Arthur P. Bollon
- Erfahrung
